Horan Securities, Inc. Organon & Co. Transaction History

Horan Securities, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	BUY	$21.42 - $32.08 $21 - $32	1 Added 1.92%	53 $1,000
Q4 2022 Jan 17, 2023	BUY	$23.31 - $28.61 $675 - $829	29 Added 126.09%	52 $0
Q3 2022 Oct 12, 2022	SELL	$23.4 - $34.25 $608 - $890	-26 Reduced 53.06%	23 $1,000
Q2 2022 Jul 19, 2022	SELL	$31.66 - $38.9 $4,495 - $5,523	-142 Reduced 74.35%	49 $2,000
Q1 2022 May 10, 2022	BUY	$30.45 - $39.36 $30 - $39	1 Added 0.53%	191 $7,000
Q4 2021 Feb 09, 2022	SELL	$28.67 - $37.13 $172 - $222	-6 Reduced 3.06%	190 $6,000
Q2 2021 Aug 05, 2021	BUY	$28.45 - $38.0 $5,576 - $7,448	196 New	196 $6,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on Horan Securities, Inc. with notifications on news.